HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic Talc Study Does Not Justify Human Carcinogen Listing - CTFA

This article was originally published in The Rose Sheet

Executive Summary

Evidence published by NIH's NIEHS/National Toxicology Program does not validate listing cosmetic talc as a probable human carcinogen, the Cosmetic, Toiletry and Fragrance Association said.

You may also be interested in...



Rat Overload Particle Exposure Is Not Predictive For Humans, Analysis Finds

An analysis of the National Toxicology Program's Draft Report on Talc finds the result of overload exposure to "poorly soluble, low toxigenic and non-genotoxic" particles in rats is not predictive for humans, according to Donald Dungworth, PhD, University of California.

Rat Overload Particle Exposure Is Not Predictive For Humans, Analysis Finds

An analysis of the National Toxicology Program's Draft Report on Talc finds the result of overload exposure to "poorly soluble, low toxigenic and non-genotoxic" particles in rats is not predictive for humans, according to Donald Dungworth, PhD, University of California.

Vaginal Talc Use Not Related To Ovarian Cancer, NCI Study Finds

Perineal talc use is not associated with the risk of epithelial ovarian cancer, according to a study published in the Feb. 2 issue of the Journal of the National Cancer Institute.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008620

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel